Grace Rose
Internal Medicine · Raleigh, NCNPI 1275581944
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,017 and has fallen 97.6% since, to $25 in 2023.
Across 161 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$422
- Lilly USA, LLC$251
- Pfizer$221
- Amgen$204
- AstraZeneca$197
- AbbVie$176
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,52499%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 26 | $422 |
| Lilly USA, LLC | 15 | $251 |
| Pfizer | 14 | $221 |
| Amgen | 14 | $204 |
| AstraZeneca | 13 | $197 |
| AbbVie(2 entities) | 11 | $176 |
| Boehringer Ingelheim | 9 | $147 |
| Amarin Pharma, Inc. | 8 | $118 |
| Abbott | 4 | $100 |
| GSK | 6 | $94 |
| Astellas Pharma US Inc | 4 | $92 |
| Jazz Pharmaceuticals Inc. | 5 | $75 |
| Johnson & Johnson | 4 | $60 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Adlon Therapeutics L.p. | 3 | $41 |
| Sanofi Pasteur Inc. | 3 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $39 |
| Therapeuticsmd, Inc. | 3 | $36 |
| Eisai Inc. | 2 | $31 |
| IBSA Pharma Inc. | 2 | $31 |
| Merck | 2 | $23 |
| Corcept Therapeutics | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Gilead | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Zealand Pharma US, Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,559 in reported general payments places this provider in the 85th percentile of 3,302 internal medicine providers in North Carolina.
Other internal medicine in Raleigh
- Bhakti PaulRaleigh$536K
- Christina CraterRaleigh$330K
- Charles CookRaleigh$228K
- Anthony AzziRaleigh$81K
- Dishita PandyaRaleigh$71K
- Afreen ShariffRaleigh$66K
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Mary KlotmanDurham$478K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.